AU5679394A - Hepatitis b virus vaccines - Google Patents

Hepatitis b virus vaccines

Info

Publication number
AU5679394A
AU5679394A AU56793/94A AU5679394A AU5679394A AU 5679394 A AU5679394 A AU 5679394A AU 56793/94 A AU56793/94 A AU 56793/94A AU 5679394 A AU5679394 A AU 5679394A AU 5679394 A AU5679394 A AU 5679394A
Authority
AU
Australia
Prior art keywords
hepatitis
virus vaccines
vaccines
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU56793/94A
Inventor
Edward G Bernstine
Tatyana Lewis
Rhonda Wilson O'Keefe
Peter T. S Souw
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
INTERNATIONAL BIOTECHNOLOGY LABORATORIES Inc
Original Assignee
INT BIOTECHNOLOGY LAB Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by INT BIOTECHNOLOGY LAB Inc filed Critical INT BIOTECHNOLOGY LAB Inc
Publication of AU5679394A publication Critical patent/AU5679394A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24151—Methods of production or purification of viral material

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU56793/94A 1992-11-25 1993-11-24 Hepatitis b virus vaccines Abandoned AU5679394A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US98221192A 1992-11-25 1992-11-25
US982211 1992-11-25
PCT/US1993/011474 WO1994012617A1 (en) 1992-11-25 1993-11-24 Hepatitis b virus vaccines

Publications (1)

Publication Number Publication Date
AU5679394A true AU5679394A (en) 1994-06-22

Family

ID=25528946

Family Applications (1)

Application Number Title Priority Date Filing Date
AU56793/94A Abandoned AU5679394A (en) 1992-11-25 1993-11-24 Hepatitis b virus vaccines

Country Status (2)

Country Link
AU (1) AU5679394A (en)
WO (1) WO1994012617A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1063756C (en) * 1997-10-06 2001-03-28 中国科学院上海生物化学研究所 Double antigen contg hepatitis B virus and hepatitis C virus core antigen simultaneously
AUPP706098A0 (en) * 1998-11-11 1998-12-03 North Western Health Care Network Biological compositions, components thereof and uses therefor
CU22871A1 (en) * 1998-12-02 2003-10-21 Ct Ingenieria Genetica Biotech FORMULATIONS CONTAINING PARTICULARS SIMILAR TO VIRUS AS IMMUNOPOTENCERS BY MUCOSAL ROUTE
FR2803599B1 (en) * 2000-01-06 2004-11-19 Inst Nat Sante Rech Med NEW MUTATED HEPATITIS B VIRUS, ITS NUCLEIC AND PROTEIN CONSTITUENTS AND THEIR APPLICATIONS
US8138318B2 (en) * 2007-09-13 2012-03-20 Abbott Laboratories Hepatitis B pre-S2 nucleic acid
CN102233137B (en) * 2010-04-30 2013-02-20 北京凯因科技股份有限公司 Recombinant plasmid DNA vaccine composition for treating Hepatitis B
CN102233136B (en) * 2010-04-30 2013-05-08 北京凯因科技股份有限公司 Recombinant plasmid vaccine for treating hepatitis B and composition thereof
AP2013007110A0 (en) 2011-02-12 2013-09-30 Globeimmune Inc Yeast-based therapeutic for chronic hepatitis B infection
AU2017206102C1 (en) 2016-01-08 2022-02-10 Geovax Inc. Compositions and methods for generating an immune response to a tumor associated antigen
US11311612B2 (en) 2017-09-19 2022-04-26 Geovax, Inc. Compositions and methods for generating an immune response to treat or prevent malaria
CN112521492B (en) * 2020-12-18 2022-05-20 杭州贤至生物科技有限公司 Preparation of hepatitis B surface antigen monoclonal antibody

Also Published As

Publication number Publication date
WO1994012617A1 (en) 1994-06-09

Similar Documents

Publication Publication Date Title
AU2371692A (en) Recombinant hepatitis a virus vaccine
AU6304996A (en) Vaccines against hepatitis c
AU2550995A (en) Hepatitis c virus asialoglycoproteins
AU4878096A (en) Hepatitis b vaccine
AU4325089A (en) Viral vaccines
AU3434393A (en) Targeted virus
AU9052091A (en) Vaccines based on hepatitis b surface antigen
AU4450093A (en) Hepatitis A virus vaccine
AU5679394A (en) Hepatitis b virus vaccines
AU1522792A (en) Multiple hepatitis b virus surface proteins which form particles
AU3232995A (en) Hepatitis a virus deletion mutants and vaccine formulations containing the same
AU2961195A (en) Chicken infectious anemia virus vaccine
AU2347692A (en) Recombinant viral vaccine
AU7679491A (en) Hepatitis c virus protease inhibitors
AU688259B2 (en) Hepatitis C virus peptides
HU9203976D0 (en) Vaccine based on modified herpes virus
AU4970193A (en) IPNV vaccine
AU4399197A (en) Hepatitis c virus epitope
HU0400424D0 (en) Hepatitis virus vaccines
GB9124696D0 (en) Hepatitis c virus
IL106609A0 (en) Hepatitis a virus vaccine
AU8406191A (en) Infectious laryngotracheitis virus vaccine
GB9305710D0 (en) Viral vaccines
GB9324964D0 (en) Viral vaccines
HK1001542A1 (en) Hepatitis e virus vaccine and method.